Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Holdhoff

High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma

Neurology

2014

English

The Immunodynamics of Myeloid-Derived Suppressor Cell and Monocyte Populations in the Peripheral Blood in Patients With Newly Diagnosed Glioblastoma Undergoing Adjuvant Temozolomide and Radiation Therapy

International Journal of Radiation Oncology Biology Physics

English

Related publications

Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab

Journal of Neuro-Oncology

English

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

Journal of Clinical Oncology

English

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma

Neurology

2011

English

BICENTRIC PILOT STUDY ON AGE-ADAPTED HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA PATIENTS > 65 YEARS - MARiTA TRIAL

Hematological Oncology

English

Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

British Journal of Haematology

Hematology

2016

English

Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score

Hematological Oncology

English

Neutrophilic Eccrine Hidradenitis in a Primary CNS Lymphoma Patient Receiving High-Dose Chemotherap

Dermatology Case Reports

2019

English

Treatment of Primary Mediastinal Large B Cell Lymphoma With an Alternating Chemotherapy Regimen Based on High-Dose Methotrexate

English

Rituximab, Lenalidomide, and Ibrutinib Alone and Combined With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Holdhoff

High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma

The Immunodynamics of Myeloid-Derived Suppressor Cell and Monocyte Populations in the Peripheral Blood in Patients With Newly Diagnosed Glioblastoma Undergoing Adjuvant Temozolomide and Radiation Therapy

Related publications

Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma

BICENTRIC PILOT STUDY ON AGE-ADAPTED HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA PATIENTS > 65 YEARS - MARiTA TRIAL

Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score

Neutrophilic Eccrine Hidradenitis in a Primary CNS Lymphoma Patient Receiving High-Dose Chemotherap

Treatment of Primary Mediastinal Large B Cell Lymphoma With an Alternating Chemotherapy Regimen Based on High-Dose Methotrexate

Rituximab, Lenalidomide, and Ibrutinib Alone and Combined With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma